IMMUNOGENICITY OF HIV CANDIDATE VACCINES IN BABOONS

HIV 候选疫苗对狒狒的免疫原性

基本信息

  • 批准号:
    7562492
  • 负责人:
  • 金额:
    $ 2.17万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-05-01 至 2008-04-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Human immunodeficiency virus (HIV) was identified as the causative agent of AIDS more then 21 years ago and the virus has killed approximately 23 million people and is estimated to have infected nearly 46 million people worldwide. No effective vaccine is available for prevention of further spread of the virus. In this proposal, we will examine the immunogenicity of novel candidate AIDS vaccines in the baboon model to hopefully identify a suitable vaccine formulation for human trials. A total of 60 baboons are requested for the proposed project. Groups of 8 to 12 baboons will be used for testing the immunogenicity of different candidate vaccines. We plan to use 8 to 12 baboons for testing the immunogenicity of each candidate vaccine at 6 to 8 month intervals. Therefore, the total number of vaccine candidates tested will range from 5-7. The experimental objective for the entire proposal is to evaluate the relative immunogenicity of different vaccine candidates.
这个子项目是众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KRISHNA H MURTHY其他文献

KRISHNA H MURTHY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KRISHNA H MURTHY', 18)}}的其他基金

DEFINING THE HCV INFECTIOUS WINDOW PERIOD IN THE CHIMPANZEE
黑猩猩 HCV 感染窗口期的定义
  • 批准号:
    7562417
  • 财政年份:
    2007
  • 资助金额:
    $ 2.17万
  • 项目类别:
CHIMPANZEES FOR HEPATITIS OR AIDS RESEARCH
黑猩猩用于肝炎或艾滋病研究
  • 批准号:
    7562410
  • 财政年份:
    2007
  • 资助金额:
    $ 2.17万
  • 项目类别:
NEOANTIGENICITY OF RIBOFLAVIN AND LIGHT TREATED RBCS IN BABOONS
狒狒核黄素和光处理红细胞的新抗原性
  • 批准号:
    7562491
  • 财政年份:
    2007
  • 资助金额:
    $ 2.17万
  • 项目类别:
DEVELOPMENT OF HEPATITIS C VIRUS-LIKE PARTICLES AS CANDIDATE HCV VACCINE
开发丙型肝炎病毒样颗粒作为候选 HCV 疫苗
  • 批准号:
    7562406
  • 财政年份:
    2007
  • 资助金额:
    $ 2.17万
  • 项目类别:
IMMUNOGENETHERAPY OF CHRONIC HCV CARRIER CHIMPANZEES
慢性 HCV 携带者黑猩猩的免疫基因治疗
  • 批准号:
    7562457
  • 财政年份:
    2007
  • 资助金额:
    $ 2.17万
  • 项目类别:
DEVELOPMENT OF HEPATITIS C VIRUS-LIKE PARTICLES AS CANDIDATE HCV VACCINE
开发丙型肝炎病毒样颗粒作为候选 HCV 疫苗
  • 批准号:
    7349750
  • 财政年份:
    2006
  • 资助金额:
    $ 2.17万
  • 项目类别:
SYNTHETIC IGE PEPTIDE VACCINE FOR IMMUNOTHERAPY OF ALLERGY
用于过敏免疫治疗的合成 IGE 肽疫苗
  • 批准号:
    7349812
  • 财政年份:
    2006
  • 资助金额:
    $ 2.17万
  • 项目类别:
CHIMPANZEES FOR HEPATITIS OR AIDS RESEARCH
黑猩猩用于肝炎或艾滋病研究
  • 批准号:
    7349754
  • 财政年份:
    2006
  • 资助金额:
    $ 2.17万
  • 项目类别:
DEFINING THE HCV INFECTIOUS WINDOW PERIOD IN THE CHIMPANZEE
黑猩猩 HCV 感染窗口期的定义
  • 批准号:
    7349765
  • 财政年份:
    2006
  • 资助金额:
    $ 2.17万
  • 项目类别:
NEUTRALIZING ANTIBODY INDUCTION IN BABOONS
中和狒狒中的抗体诱导
  • 批准号:
    7349811
  • 财政年份:
    2006
  • 资助金额:
    $ 2.17万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 2.17万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 2.17万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 2.17万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 2.17万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 2.17万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 2.17万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 2.17万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 2.17万
  • 项目类别:
Studies on cofactors for development of acquired immunodeficiency syndrome in feline immunodeficiency virus infection.
猫免疫缺陷病毒感染后获得性免疫缺陷综合征发生的辅助因子研究。
  • 批准号:
    03660315
  • 财政年份:
    1991
  • 资助金额:
    $ 2.17万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 2.17万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了